Abstract
Eighteen patients entered a double-blind trial of the beta-adrenergic blocking drug Trasicor in the treatment of angina pectoris. Six patients had to be withdrawn from the trial when substitution of placebo for Trasicor caused severe exacerbation of angina attacks. In these cases the frequency and severity of angina attacks fell to a minimum when Trasicor was re-established. A further 10 patients were significantly improved by Trasicor. Two patients showed no significant improvement. No side-effects were observed in doses ranging up to 400 mg. daily.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Frohlich E. D., Tarazi R. C., Dustan H. P., Page I. H. The paradox of beta-adrenergic blockade in hypertension. Circulation. 1968 Mar;37(3):417–423. doi: 10.1161/01.cir.37.3.417. [DOI] [PubMed] [Google Scholar]
- GILLAM P. M., PRICHARD B. N. USE OF PROPRANOLOL IN ANGINA PECTORIS. Br Med J. 1965 Aug 7;2(5457):337–339. doi: 10.1136/bmj.2.5457.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waal H. J. Propranolol-induced depression. Br Med J. 1967 Apr 1;2(5543):50–50. doi: 10.1136/bmj.2.5543.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson D. F., Turner A. S. Trasicor (39,089/Ba) in angina pectoris. A single-blind trial. N Z Med J. 1968 Mar;67(430):406–407. [PubMed] [Google Scholar]
- Wilson D. F., Watson O. F., Peel J. S., Langley R. B., Turner A. S. Some haemodynamic effects of trasicor (Ciba 39,089-Ba). N Z Med J. 1968 Sep;68(436):145–149. [PubMed] [Google Scholar]
- Wolfson S., Heinle R. A., Herman M. V., Kemp H. G., Sullivan J. M., Gorlin R. Propranolol and angina pectoris. Am J Cardiol. 1966 Sep;18(3):345–353. doi: 10.1016/0002-9149(66)90052-x. [DOI] [PubMed] [Google Scholar]
